Pretreatment of mice with a low hepatotoxic dose of acetaminophen (APAP) results in resistance to a subsequent, higher dose of APAP. This mouse model, termed APAP autoprotection was used here to identify differentially expressed genes and cellular pathways that could contribute to this development of resistance to hepatotoxicity. Male C57BL/6J mice were pretreated with APAP (400mg/kg) and then challenged 48h later with 600mg APAP/kg. Livers were obtained 4 or 24h later and total hepatic RNA was isolated and hybridized to Affymetrix Mouse Genome MU430_2 GeneChip. Statistically significant genes were determined and gene expression changes were also interrogated using the Causal Reasoning Engine (CRE). Extensive literature review narrowed our focus to methionine adenosyl transferase-1 alpha (MAT1A), nuclear factor (erythroid-derived 2)-like 2 (Nrf2), flavin-containing monooxygenase 3 (Fmo3) and galectin-3 (Lgals3). Down-regulation of MAT1A could lead to decreases in S-adenosylmethionine (SAMe), which is known to protect against APAP toxicity. Nrf2 activation is expected to play a role in protective adaptation. Up-regulation of Lgals3, one of the genes supporting the Nrf2 hypothesis, can lead to suppression of apoptosis and reduced mitochondrial dysfunction. Fmo3 induction suggests the involvement of an enzyme not known to metabolize APAP in the development of tolerance to APAP toxicity. Subsequent quantitative RT-PCR and immunochemical analysis confirmed the differential expression of some of these genes in the APAP autoprotection model. In conclusion, our genomics strategy identified cellular pathways that might further explain the molecular basis for APAP autoprotection.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901410 | PMC |
| http://dx.doi.org/10.1016/j.taap.2013.09.025 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Single-cell RNA sequencing reveals the dynamics of hepatic non-parenchymal cells in autoprotection against acetaminophen-induced hepatotoxicity.
J Pharm Anal
August 2023
Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Article Synopsis
- A better understanding of autoprotection against drug-induced liver injury (DILI) could lead to new prevention and treatment strategies, but the underlying mechanisms are not well understood.
- Researchers used single-cell RNA sequencing to study non-parenchymal liver cells in mice pretreated with a low dose of acetaminophen (APAP) to see how they responded to a higher dose later on.
- Specific subsets of non-parenchymal cells, like endothelial and dendritic cells, were linked to liver protection and repair mechanisms, revealing potential pathways for enhancing liver resistance to acetaminophen toxicity.
From hepatoprotection models to new therapeutic modalities for treating liver diseases: a personal perspective.
F1000Res
August 2016
Toxicology Program, Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT, USA.
A variety of rodent models of hepatoprotection have been developed in which tolerance to acetaminophen-induced hepatotoxicity occurs. Autoprotection/heteroprotection is a phenomenon where prior exposure to a mildly toxic dose of toxicant confers protection against a subsequently administered higher dose of the same toxicant (as in the case of autoprotection) or to a different toxicant (referred to as heteroprotection). Multiple mechanisms regulate this adaptive response, including hepatocellular proliferation, proteostasis, enhanced expression of cytoprotective genes, and altered tissue immune response.
View Article and Find Full Text PDFAdaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome.
Sci Rep
November 2015
MRC Centre for Drug Safety Science, University of Liverpool, Liverpool L69 3GE, UK.
Article Synopsis
- * The study uses quantitative mass spectrometry to analyze the liver's response to acetaminophen in rats, finding that 30% of all detected liver proteins are involved in this response.
- * A master regulator of cellular defense, NFE2L2, has minimal impact on this adaptation, indicating that multiple pathways may contribute, while changes in protein localization may help avoid reaching toxic levels.
Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.
Toxicol Sci
September 2014
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, Connecticut 06269
Acetaminophen (APAP) pretreatment with a hepatotoxic dose (400 mg/kg) in mice results in resistance to a second, higher dose (600 mg/kg) of APAP (APAP autoprotection). Recent microarray work by our group showed a drastic induction of liver flavin containing monooxygenase-3 (Fmo3) mRNA expression in our mouse model of APAP autoprotection. The role of liver Fmo3, which detoxifies xenobiotics, in APAP autoprotection is unknown.
View Article and Find Full Text PDFAnalysis of changes in hepatic gene expression in a murine model of tolerance to acetaminophen hepatotoxicity (autoprotection).
Toxicol Appl Pharmacol
January 2014
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269-3092, USA. Electronic address:
Pretreatment of mice with a low hepatotoxic dose of acetaminophen (APAP) results in resistance to a subsequent, higher dose of APAP. This mouse model, termed APAP autoprotection was used here to identify differentially expressed genes and cellular pathways that could contribute to this development of resistance to hepatotoxicity. Male C57BL/6J mice were pretreated with APAP (400mg/kg) and then challenged 48h later with 600mg APAP/kg.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!